Apr 30, 2019 / Congressional Testimony

Testimony: Payment Policy for Prescription Drugs Under Medicare Part B and Part D (Energy and Commerce)

Research Areas:

Drugs, Devices, and Tests

Apr 09, 2019 / Transcripts

April 2019 meeting transcript

Apr 05, 2019 / Presentations

Improving payment for low-volume and isolated outpatient dialysis facilities

Research Areas:

Ambulatory Care Settings, Regional Issues

Apr 05, 2019 / Presentations

Options to increase the affordability of specialty drugs and biologics in Medicare Part D

Research Areas:

Drugs, Devices, and Tests, Private Plans

Apr 05, 2019 / Comment Letters

MedPAC comment on OIG’s proposed rule on safe harbor regulation of prescription drug rebates

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Medicare Spending and Financing

Apr 04, 2019 / Presentations

Medicare Shared Savings Program (MSSP) performance

Research Areas:

Delivery System Reforms, Physicians And Other Health Professionals, Quality

Apr 04, 2019 / Presentations

Options for slowing the growth of Medicare fee-for-service spending for emergency department services

Research Areas:

Hospitals, Medicare Spending and Financing

Apr 04, 2019 / Presentations

Evaluating patient functional assessment data reported by post-acute care providers

Research Areas:

Post-Acute Care, Quality

Apr 04, 2019 / Presentations

Increasing the accuracy and completeness of Medicare Advantage encounter data

Research Areas:

Private Plans

Apr 04, 2019 / Presentations

Redesigning the Medicare Advantage quality bonus program

Research Areas:

Private Plans, Quality